메뉴 건너뛰기





Volumn 27, Issue SUPPL. 2, 2003, Pages

Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANTIOBESITY AGENT; BIGUANIDE DERIVATIVE; DACLIZUMAB; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLUCONORM; HUMAN INSULIN; HUMULIN L; HUMULIN U; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; INSULIN SENSITIZING AGENT; ISOPHANE INSULIN; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PNEUMOCOCCUS VACCINE; PRANDASE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TACROLIMUS; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 0347867354     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (465)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.